In the context of NAFLD, steatotic hepatocytes exhibit a strong response to IL-17A, leading to the upregulation of IL-17RA and increased production of proinflammatory and fibrogenic cytokines (e.g., IL-6 and TNF-α) (55–57). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.